sparfloxacin has been researched along with Malignant Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asahig, K; Hamanaka, H; Mizutani, H; Shimizu, M | 1 |
1 other study(ies) available for sparfloxacin and Malignant Melanoma
| Article | Year |
|---|---|
Melanocyte melanin augments sparfloxacin-induced phototoxicity.
Topics: Anti-Infective Agents; Cell Survival; Dermatitis, Phototoxic; Drug Hypersensitivity; Fluoroquinolones; Humans; Melanins; Melanocytes; Melanoma; Melanoma, Amelanotic; Tumor Cells, Cultured; Ultraviolet Rays | 1999 |